The Study
BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide’s Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Pharmaceuticals 2025, 18, 185
This isn't a real experiment — it's like someone writing a letter saying, 'I think this medicine is great based on what I've read.' They didn't test it themselves, so we can't say for sure it works. It's just their opinion, not proof.
Analysis score
Maximum 0 for a editorial/opinion.
Where the score came from
BPC 157 is a tiny protein fragment that helps the body heal damaged tissues—like the eye, brain, and blood vessels—without making tumors grow or causing side effects. It doesn’t just boost healing; it fixes broken systems by calming too much inflammation or too little blood flow, depending on what’s wrong.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 50 / 100
Quality score
Based on clinical experience or non-systematic literature reviews. The lowest level of evidence as they are most susceptible to bias and personal perspective.
Key takeaways
Summary
Based on the study abstract and findings.
- 1These results suggest BPC 157 could one day help treat human conditions like eye injuries, Parkinson’s, Alzheimer’s, cancer-related wasting, or liver disease—but only if proven safe and effective in people.
- 2In rats and mice, BPC 157 prevented blindness from corneal injury, improved movement and memory in brain disease models, shrank tumors, and reversed liver and blood vessel damage—all without causing harm.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Pharmaceuticals
Year
2025
Authors
Predrag Sikiric, Sven Seiwerth, Anita Skrtic, Mario Staresinic, Sanja Strbe, Antonia Vuksic, Suncana Sikiric, Dinko Bekic, Dragan Soldo, Boris Grizelj, Luka Novosel, Lidija Beketic Oreskovic, Ivana Oreskovic, Mirjana Stupnisek, Alenka Boban Blagaic, Ivan Dobric
Related Content
Claims (5)
In rats with corneal injury, BPC 157 reduces abnormal blood vessel growth in the cornea and maintains clear vision without triggering new blood vessel formation.
In rodents with brain damage resembling Parkinson’s and Alzheimer’s diseases, BPC 157 reduces movement problems, memory loss, and neuron death, including in brain regions critical for movement and memory, by altering neurotransmitter activity and nitric oxide signaling.
In mice and other animal models with colon cancer or melanoma, BPC 157 decreases tumor size, prevents cancer spread, and stops muscle loss and weight loss by reducing inflammatory signaling molecules and altering VEGF pathway activity.
BPC 157 adjusts nitric oxide levels up or down depending on the disease condition and consistently lowers markers of oxidative stress like malondialdehyde.
BPC 157 lowers elevated blood pressure in the liver's blood vessels and repairs damaged blood vessel function in animals with liver scarring or blocked blood vessels, without affecting blood clotting.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.